BioClonal's FIC against Alzheimer's disease in "Heraldo de Aragón".
2023 Apr 23
In 2023 we start our mAbs development to fight this disease, based on a new approach not yet experimented.
Bioclonal has targeted AB-BC as the root cause unleashing AD. A person with AB-BC will suffer Alzheimer´s. In fact, once this target appears, the person is already sick, altough not diagnosed and without symptons. It is a holistic approach.
Today, BioClonal and its research against Alzheimer's disease was announced in the Economy section of Heraldo de Aragón.
We can't be more proud!
Read the full article here.